Choosing Wisely Africa: Ten Low-Value or Harmful Practices That Should Be Avoided in Cancer Care.


Journal

JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170

Informations de publication

Date de publication:
07 2020
Historique:
entrez: 1 8 2020
pubmed: 1 8 2020
medline: 29 7 2021
Statut: ppublish

Résumé

Choosing Wisely Africa (CWA) builds on Choosing Wisely (CW) in the United States, Canada, and India and aims to identify low-value, unnecessary, or harmful cancer practices that are frequently used on the African continent. The aim of this work was to use physicians and patient advocates to identify a short list of low-value practices that are frequently used in African low- and middle-income countries. The CWA Task Force was convened by the African Organization for Research and Training in Cancer and included representatives from surgical, medical, and radiation oncology, the private and public sectors, and patient advocacy groups. Consensus was built through a modified Delphi process, shortening a long list of practices to a short list, and then to a final list. A voting threshold of ≥ 60% was used to include an individual practice on the short list. A consensus was reached after a series of teleconferences and voting processes. Of the 10 practices on the final list, one is a new suggestion and 9 are revisions or adaptations of practices from previous CW campaign lists. One item relates to palliative care, 8 concern treatment, and one relates to surveillance. The CWA initiative has identified 10 low-value, common interventions in Africa's cancer practice. The success of this campaign will be measured by how the recommendations are implemented across sub-Saharan Africa and whether this improves the delivery of high-quality cancer care.

Identifiants

pubmed: 32735489
doi: 10.1200/GO.20.00255
pmc: PMC7392774
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1192-1199

Références

Lancet Oncol. 2017 Aug;18(8):1000-1002
pubmed: 28759361
J Palliat Med. 2005 Dec;8(6):1214-25
pubmed: 16351535
Lancet Oncol. 2019 Apr;20(4):e218-e223
pubmed: 30857957
Ann Surg Oncol. 2012 May;19(5):1508-16
pubmed: 22193884
Pan Afr Med J. 2018 Nov 15;31:185
pubmed: 31086635
Curr Oncol. 2017 Jun;24(3):201-206
pubmed: 28680281
Radiother Oncol. 2014 Apr;111(1):11-7
pubmed: 24560750
J Clin Oncol. 2011 Feb 20;29(6):755-60
pubmed: 21263086
BMJ. 1996 Sep 14;313(7058):665-9
pubmed: 8811760
J Clin Oncol. 2005 Nov 20;23(33):8512-9
pubmed: 16260687
Indian J Surg Oncol. 2020 Mar;11(1):4-6
pubmed: 32205959
J Clin Oncol. 2013 Dec 10;31(35):4465-70
pubmed: 24220554
Ann Surg Oncol. 2011 Dec;18(13):3802-10
pubmed: 21630122
Breast. 2012 Jun;21(3):242-52
pubmed: 22425534
Curr Oncol. 2019 Jun;26(3):e309-e313
pubmed: 31285673
J Am Coll Surg. 2012 Oct;215(4):562-8
pubmed: 22726895
J Surg Oncol. 2014 Oct;110(5):494-9
pubmed: 24986235
J Glob Oncol. 2017 Jan 18;3(5):441-443
pubmed: 29094081
J Clin Oncol. 2015 Sep 20;33(27):3065-73
pubmed: 26304881
Lancet Oncol. 2014 Feb;15(2):164-71
pubmed: 24369114
Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1501-10
pubmed: 19464820
J Clin Oncol. 2011 Oct 1;29(28):3825-31
pubmed: 21900105
Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):965-76
pubmed: 21277118
J Clin Oncol. 2004 May 15;22(10):2008-14
pubmed: 15143094
N Engl J Med. 2012 Oct 25;367(17):1616-25
pubmed: 23094723
J Clin Oncol. 2007 Apr 10;25(11):1423-36
pubmed: 17416863
J Clin Oncol. 2012 May 10;30(14):1715-24
pubmed: 22493340
Lancet Oncol. 2008 Apr;9(4):331-41
pubmed: 18356109
PLoS One. 2013 Sep 12;8(9):e72712
pubmed: 24069156
J Pain Symptom Manage. 2008 Jul;36(1):22-8
pubmed: 18411019
N Engl J Med. 2016 Oct 13;375(15):1415-1424
pubmed: 27626136
BMC Med Res Methodol. 2016 May 20;16:56
pubmed: 27206853
Lancet. 2000 Sep 9;356(9233):888-93
pubmed: 11036893
Ann Behav Med. 2019 Jun 4;53(7):674-685
pubmed: 30265282
JAMA. 2018 May 15;319(19):1975-1976
pubmed: 29710232
J Urol. 2018 Mar;199(3):683-690
pubmed: 29203269
Lancet Oncol. 2018 Mar;19(3):288-290
pubmed: 29508746
J Natl Compr Canc Netw. 2012 Oct 1;10(10):1236-71
pubmed: 23054877
J Palliat Med. 2006 Aug;9(4):894-902
pubmed: 16910804
J Clin Oncol. 2002 Aug 15;20(16):3396-403
pubmed: 12177099
J Clin Oncol. 2013 Mar 1;31(7):961-5
pubmed: 23129741
Lancet Glob Health. 2018 Nov;6(11):e1196-e1252
pubmed: 30196093
Pract Radiat Oncol. 2018 Nov - Dec;8(6):354-360
pubmed: 30322661
Cancer. 2009 Jan 15;115(2):437-45
pubmed: 19107768
Ann Surg Oncol. 2014 Mar;21(3):738-46
pubmed: 24271157
Radiology. 1999 Jul;212(1):181-8
pubmed: 10405740
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Oncol Pract. 2015 May;11(3):239-46
pubmed: 25873056
J Oncol Pract. 2015 May;11(3):e296-303
pubmed: 25980018
Eur J Cancer. 2014 Feb;50(3):475-80
pubmed: 24321260
Dis Colon Rectum. 2015 Aug;58(8):713-25
pubmed: 26163950

Auteurs

Fidel Rubagumya (F)

Rwanda Military Hospital, Kigali, Rwanda.
University of Global Health Equity, Burera, Rwanda.

Gunita Mitera (G)

University of Toronto, Toronto, Ontario, Canada.

Sidy Ka (S)

Joliot Curie Cancer Institute, Dakar, Senegal.

Achille Manirakiza (A)

Rwanda Military Hospital, Kigali, Rwanda.

Philippa Decuir (P)

Breast Cancer Initiative East Africa, Kigali, Rwanda.

Susan C Msadabwe (SC)

Cancer Diseases Hospital, Ministry of Health, Lusaka, Zambia.

Solange Adani Ifè (S)

Sylvanus Olympio Teaching Hospital, Lomé, Togo.

Emmanuella Nwachukwu (E)

National Hospital Abuja, Nigeria.

Naomi Ohene Oti (N)

Korle Bu Teaching Hospital, Accra, Ghana.

Hirondina Borges (H)

Hospital Agostinho Neto, Praia, Cabo Verde.

Miriam Mutebi (M)

Aga Khan University Hospital, Nairobi, Kenya.

Dafalla Abuidris (D)

National Cancer Institute, University of Geriza, Wad Madani, Sudan.

Verna Vanderpuye (V)

Korle Bu Teaching Hospital, Accra, Ghana.

Christopher M Booth (CM)

Kingston Health Science Center, Queen's University, Kingston, Ontario, Canada.

Nazik Hammad (N)

Kingston Health Science Center, Queen's University, Kingston, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH